Procedural eptifibatide administration as an alternative to preprocedural dual antiplatelet therapy for patients undergoing flow diversion procedures: case series and review of the literature
Intraprocedural eptifibatide may be an acceptable alternative to preprocedural DAPT to achieve platelet inhibition for FD procedures. This protocol did not result in peripheral or neurological hemorrhagic complications and was associated with a very low incidence of post-procedure diffusion lesions.
Authors
- Wesam Andraous
- Seyed Morsal Mosallami Aghili (ORCID: https://orcid.org/0000-0002-7372-0143)
- S. Grondin (ORCID: https://orcid.org/0000-0002-0444-8502)
- David J. Fiorella (ORCID: https://orcid.org/0000-0002-2677-8780)
- Sofia Geralemou
- Reza Dashti (ORCID: https://orcid.org/0000-0002-2257-262X)
- Christine M Denice
- Daniel A. Symonds
- Ana Costa (ORCID: https://orcid.org/0000-0002-1816-6194)
- Vishal K. Patel
- Catherine Clark
- Diana Santori
- Kristy Pellicone
- Jean Delisi
Institutions
- Stony Brook Medicine (US)
Publication Details
- Journal
- Journal of NeuroInterventional Surgery
- Published
- 2025-11-30
- DOI
- https://doi.org/10.1136/jnis-2025-024406
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00